EUVIMEDEUVIMED entdecken
Crossref

Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia

Chi Kin Law, Anne E Cust, Amelia K Smit, Lyndal Trevena, Pablo Fernandez-Penas, Omgo E Nieweg, Alexander M Menzies, Sarah Wordsworth, Rachael L Morton, Managing Your Risk Study Group

Genetics in Medicine · 2023

DOI: 10.1016/j.gim.2023.100970 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics in Medicine, 2023. Verfasst von Chi Kin Law und 9 weiteren Autor:innen. Beteiligte Einrichtung: NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia. Electronic address: chi.law@sydney.edu.au. Hauptthemen laut MEDLINE: Melanoma, Sunburn. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Medical Research Council, NHMRC, The University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Evidence indicates that a melanoma prevention program using personalized genomic risk provision and genetic counseling can affect prevention behaviors, including reducing sunburns in adults with no melanoma history. This analysis evaluated its longer-term cost-effectiveness from an Australian health system perspective. METHODS: The primary outcome was incremental cost effectiveness ratio (ICER) of genomic risk provision (intervention) compared with standard prevention advice. A decision-analytic Markov model was developed using randomized trial data to simulate lifetime cost-effectiveness. All costs were presented in 2018/19 Australian dollars (AUD). The intervention effect on reduced sunburns was stratified by sex and traditional risk, which was calculated through a validated prediction model. Deterministic and probabilistic sensitivity analyses were undertaken for robustness checks. RESULTS: The per participant cost of intervention was AUD$189. Genomic risk provision targeting high-traditional risk individuals produced an ICER of AUD$35,254 (per quality-adjusted life year gained); sensitivity analyses indicated the intervention would be cost-effective in more than 50% of scenarios. When the intervention was extended to low-traditional risk groups, the ICER was AUD$43,746 with a 45% probability of being cost-effective. CONCLUSION: Genomic risk provision targeted to high-traditional melanoma risk individuals is likely a cost-effective strategy for reducing sunburns and will likely prevent future melanomas and keratinocyte carcinomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSunburnAdultHumansAustraliaCost-Benefit AnalysisCost-Effectiveness AnalysisGenomicsRisk FactorsQuality-Adjusted Life Years

Stichwörter der Autor:innen

Cost-Effectiveness AnalysisGenomicsPreventionSkin NeoplasmsSunburn

Autor:innen und Institutionen

  • NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia. Electronic address: chi.law@sydney.edu.au.
  • The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; School of Public Health, The Universi…
  • School of Public Health, The University of Sydney, Sydney, Australia.
  • Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia.

Förderung

  • Medical Research Council
  • NHMRC
  • The University of Sydney
  • Melanoma Institute Australia

Zitieren

APA

Law, C. K., Cust, A. E., Smit, A. K., Trevena, L., Fernandez-Penas, P., Nieweg, O. E., Menzies, A. M., Wordsworth, S., Morton, R. L., & Managing Your Risk Study Group (2023). Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia. Genetics in Medicine. https://doi.org/10.1016/j.gim.2023.100970

Vancouver

Law CK, Cust AE, Smit AK, Trevena L, Fernandez-Penas P, Nieweg OE, et al. Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia. Genetics in Medicine. 2023. doi:10.1016/j.gim.2023.100970

BibTeX
@article{Law2023,
  author = {Law, Chi Kin and Cust, Anne E and Smit, Amelia K and Trevena, Lyndal and Fernandez-Penas, Pablo and Nieweg, Omgo E and Menzies, Alexander M and Wordsworth, Sarah and Morton, Rachael L and Managing Your Risk Study Group, Managing Your Risk Study Group},
  title = {Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia},
  journal = {Genetics in Medicine},
  year = {2023},
  doi = {10.1016/j.gim.2023.100970}
}
Kostenlos starten →